UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to Commission File Number: 1-7293 (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification ...

Tenet Healthcare (THC) Q1 2025 Earnings Call April 29, 2025 03:01 PM ET Speaker0 Good morning, and welcome to Tenant Healthcare's First Quarter twenty twenty five Earnings Conference Call. After the speakers' remarks, there will be a question and answer session for industry analysts. I'll now turn the call over to your host, Mr. Will McDowell, Vice President, Investor Relations. Mr. McDowell, you may begin. Speaker1 Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice Pre ...

Tenet Healthcare (THC) reported $5.22 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.7%. EPS of $4.36 for the same period compares to $3.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $5.14 billion, representing a surprise of +1.64%. The company delivered an EPS surprise of +40.19%, with the consensus EPS estimate being $3.11.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...

1st Quarter 2025 Earnings Release Presentation April 29, 2025 Cautionary Statements This presentation includes "forward looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry more generally. These forward-looking statements represent management's expectations, based on ...

Tenet Healthcare (THC) Q1 2025 Earnings Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President - Investor RelationsSaum Sutaria - Chairman of The Board & CEOSun Park - Executive VP & CFOCraig Hettenbach - Executive DirectorMeghan Holtz - VP, Healthcare Services Equity ResearchBen Hendrix - Vice PresidentWhit Mayo - Senior Managing DirectorBenjamin Rossi - Equity Research AssociateA.J. Rice - Managing DirectorAndrew Mok - DirectorJoshua Raskin - Partner - Managed Care & Provid ...

Tenet Healthcare (THC) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.11 per share. This compares to earnings of $3.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40.19%. A quarter ago, it was expected that this hospital operator would post earnings of $2.93 per share when it actually produced earnings of $3.44, delivering a surprise of 17.41%.Over the last four quarters, th ...

Tenet Reports Strong First Quarter 2025 Results DALLAS — April 29, 2025 — Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2025. "We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We continue to expand access to high-quality specialty care as we effe ...

The outlook for the Zacks Medical-Hospital industry remains strong, backed by robust demand, improving financial performance, operational and staffing stability, and growth in patient stays. Expansion is further fueled by rising patient volumes and technological advancements. Although challenges like increasing salaries, benefits, supply costs and regulatory risks persist, they are expected to be offset by higher revenue per admission.Mergers and acquisitions (M&A) continue to be a key growth catalyst, enab ...

In its upcoming report, Tenet Healthcare (THC) is predicted by Wall Street analysts to post quarterly earnings of $3.11 per share, reflecting a decline of 3.4% compared to the same period last year. Revenues are forecasted to be $5.14 billion, representing a year-over-year decrease of 4.3%. Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their init ...

Core Viewpoint - Tenet Healthcare (THC) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][2] Earnings Estimates and Stock Price Movement - Changes in a company's future earnings potential, reflected in earnings estimate revisions, are strongly correlated with near-term stock price movements [3] - Institutional investors utilize earnings estimates to calculate the fair value of a company's shares, leading to stock price movements based on their buying or selling activities [3] Tenet's Earnings Outlook - The rising earnings estimates for Tenet indicate an improvement in the company's underlying business, which is expected to positively influence its stock price [4] - Analysts have raised their earnings estimates for Tenet, with the Zacks Consensus Estimate increasing by 7.3% over the past three months [7] Zacks Rank System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [6] - The upgrade of Tenet to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9]